Razaxaban

CAS No. 218298-21-6

Razaxaban( DPC 906 | DPC906 | BMS-561389 | BMS561389 )

Catalog No. M13485 CAS No. 218298-21-6

A highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Razaxaban
  • Note
    Research use only, not for human use.
  • Brief Description
    A highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM.
  • Description
    A highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM, >5,000-fold selectivity over a series of related serine proteases; inhibits thrombus formation in a dose-dependent manner with an ID50 of 1.6 μmol kg-1 h-1 in rabbit arterio-venous shunt thrombosis model.Thrombosis Phase 2 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DPC 906 | DPC906 | BMS-561389 | BMS561389
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Factor Xa
  • Recptor
    Factor Xa
  • Research Area
    Cardiovascular Disease
  • Indication
    Thrombosis

Chemical Information

  • CAS Number
    218298-21-6
  • Formula Weight
    528.472
  • Molecular Formula
    C24H20F4N8O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN(C)CC1=NC=CN1C2=CC(=C(C=C2)NC(=O)C3=CC(=NN3C4=CC5=C(C=C4)ON=C5N)C(F)(F)F)F
  • Chemical Name
    2-(3-amino-1,2-benzoxazol-5-yl)-N-[4-[2-[(dimethylamino)methyl]imidazol-1-yl]-2-fluorophenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Quan ML, et al. J Med Chem. 2005 Mar 24;48(6):1729-44. 2. Wong PC, et al. J Thromb Thrombolysis. 2007 Aug;24(1):43-51. 3. Zhang D, et al. Drug Metab Dispos. 2008 Feb;36(2):303-15.
molnova catalog
related products
  • EMD-503982

    EMD-503982 is a potential Factor Xa and Factor VIIa inhibitor with potential anticancer and antitumor activity for the study of thromboembolic and neurological disorders.

  • 4-Chlorophenylurea

    4-Chlorophenylurea is a novel orally bioavailable inhibitor of factor Xa.

  • Dechloro Rivaroxaban

    Dechloro Rivaroxaban is an orally active and highly selective Factor Xa inhibitor.Dechloro Rivaroxaban has a significant inhibitory effect on free FXa in humans.